Adara Ventures Announces First Close of €100M AV4 Fund, Targeting Cybersecurity, AI & Digital Infrastructure
Adara Ventures, the European venture capital firm specialising in early-stage deep tech investments, today announced the first close of its fourth flagship fund, AV4, targeting €100 million in capital commitments. This new fund reinforces Adara’s commitment to delivering strong returns in strategic sectors, including cybersecurity, applied AI, digital infrastructure, hardware components, digital health, and space.
“We are immensely proud to announce the successful first close of AV4,” said Nico Goulet, Founding Partner of Adara Ventures. “Over the past nine months, we have secured in excess of €140 million in commitments across our fourth-generation funds. Alongside AV4, this includes Adara Ventures Energy (AVE), our first Pan-European fund dedicated to energy transition technologies. In one of the most challenging fundraising environments of the past 20 years, our strong DPI record, disciplined investment strategy, and focused fund model make AV4 a compelling opportunity for our limited partners.”
Goulet continued: “In a sector obsessed with unicorns, our philosophy has always been to maximise ‘dragons’—companies that return the entire fund. We are proud to have generated at least one dragon in each of our previous fund generations, with AV2 poised to rank among the top 5% of VC funds in Europe for its vintage.”
Since its inception in 2005, Adara Ventures has invested in over 50 pioneering companies across Europe and the U.S., achieving more than 10 notable exits. Adara is backed by over 130 limited partners, including institutional investors, pension funds, asset managers, high-net-worth individuals, and family offices. “We are especially proud to welcome new anchor investors in this first close, as well as a new generation of Adara portfolio founders investing as LPs — a true testament to the strength of our value proposition,” Goulet added.
Adara is now actively investing from AV4 and AVE, with plans to complete the first three investments in each fund within the first half of 2025. Both funds remain open to new investors.
About Adara Ventures
Adara Ventures partners with visionary founders who have strong vision, courage, and execution capabilities. Founded in 2005, the firm manages more than €350 million in assets. Adara’s portfolio focuses on early-stage companies with a European footprint, specialising in cybersecurity, data applications and infrastructure, hardware components, digital health, space and energy transition technologies. For more information, visit www.adara.vc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250313203598/en/
Contacts
Media Contact
Ross Strachan
+34 914517070
info@adara.vc
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corona Welcomes The World To Visit Its Tropical Paradise, Corona Island18.3.2025 14:00:00 EET | Press release
Today, Corona, the world’s most valuable beer brand1, officially opens the doors to Corona Island—an eco-protected natural paradise off the coast of Colombia, now available for booking on major travel platforms. Travelers worldwide can secure their stay directly at livecoronaisland.com or through Airbnb, Expedia, and Booking.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318968356/en/ Corona Island As a beer brewed with natural ingredients, Corona Island is symbolic of the brand’s dedication to live in harmony with nature. It is more than just a destination; it offers an experience that will inspire travelers to fall in love with the natural world and motivation to protect its resources. Originally debuting in 2021 as an invite-only getaway located 20 km (12 mi) southwest of Cartagena, and accessible only by boat, the island offers guests a chance to disconnect from daily life and reconnect with nature through curate
Andy Walsky of ExaGrid Recognized on the Prestigious 2025 CRN ® Channel Leaders Lists for APAC18.3.2025 14:00:00 EET | Press release
ExaGrid®, the industry’s only Tiered Backup Storage solution with Retention Time-Lock that includes a non-network-facing tier (creating a tiered air gap), delayed deletes and immutability for ransomware recovery, today announced that CRN®, a brand of The Channel Company, has named Andy Walsky, ExaGrid’s Vice President of EMEA & APAC Sales, to the highly-anticipated 2025 CRN® Channel Leaders list for the APAC region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318899549/en/ “I am honored to be named to this list, and grateful to CRN for its coverage of the APAC region,” said Andy Walsky. “Working with channel partners is the key to success for any company and must be treated with the highest priority. My channel philosophy is to treat the channel as you would want to be treated yourself, always be fair and keep your word. Developing trust with channel partners is critical—it takes time to build, but it can be quickly ru
Armis Appoints Patrick McCue to Senior Vice President of Global Partners18.3.2025 14:00:00 EET | Press release
Armis, the cyber exposure management & security company, today announced the appointment of Patrick McCue to Senior Vice President of Global Partners. In this role, McCue will expand partner engagement and increase partner-driven revenue and services, enabling joint customers to better manage their cyber risk exposure in real time. “Armis is deeply committed to our partners. The dynamic challenges security leaders face go beyond any one organization or entity, which is why we’re partner-first and focused on collaboration to advance the industry overall,” said Alex Mosher, President of Armis. “Patrick’s proven track record in successfully driving growth through strategic partnerships makes him the ideal leader to scale Armis’ partner ecosystem and bring even greater value to our partners and customers.” “I am eager to dive in and contribute to Armis’ exceptional momentum and ongoing success of its partner program,” said McCue. “The partner community plays a critical role in extending th
SBC Medical Group to Announce Full Year 2024 Financial Results on March 28, 202518.3.2025 13:00:00 EET | Press release
SBC Medical Group Holdings Incorporated (NASDAQ: SBC, “SBC Medical”, or the “Company”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced that it will report its full year 2024 financial results before the U.S. market open on Friday, March 28, 2025. The Company will hold a conference call on Friday, March 28, 2025 at 8:00 am Eastern Time (or Friday, March 28, 2025 at 9:00 pm Japan Time) to discuss the financial results and take questions live. Please register in advance of the conference using the link provided below. It will automatically direct you to the registration page of "SBC 2024 Full Year Financial Results Briefing". Please follow the steps to enter your registration details, then click "Submit". Upon registration, you will be able to access the dedicated Conference Call viewing site. In addition to viewing the conference call, this site provides access to information about the speakers as well as past inve
Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression18.3.2025 12:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced the publication of results from the COMP004 study, an observational 52-week follow-up from the Phase 2 COMP001 and COMP003 trials of COMP360 psilocybin treatment in patients with treatment-resistant depression (TRD). The COMP004 study's findings suggest that over a 52-week period, a single administration of 25 mg COMP360 psilocybin demonstrated a longer maintenance of antidepressant effects compared to the 1 mg and 10 mg doses. The results of COMP004 build upon previous findings from the Phase 2b trial COMP001, which showed that a single 25mg dose of COMP360 psilocybin was associated with a rapid and highly statistically significant reduction in depressive symptoms compared to COMP360 1mg dose after three weeks (p<0.001), with durable response for up to 12 weeks. Key COMP004 findings Durable improvement in symptoms observed. The analysis of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom